Unichem Laboratories Limited (BOM:506690)
376.70
-7.75 (-2.02%)
At close: Jan 21, 2026
Unichem Laboratories Market Cap
Unichem Laboratories has a market cap or net worth of 26.21 billion as of January 23, 2026. Its market cap has decreased by -47.42% in one year.
Market Cap
26.21B
Enterprise Value
29.30B
Revenue
22.26B
Ranking
n/a
PE Ratio
29.66
Stock Price
376.70
Market Cap Chart
Since July 30, 2001, Unichem Laboratories's market cap has increased from 5.81B to 26.21B, an increase of 351.37%. That is a compound annual growth rate of 6.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 23, 2026 | 26.21B | -15.65% |
| Dec 31, 2025 | 31.07B | -40.43% |
| Dec 31, 2024 | 52.16B | 82.07% |
| Dec 29, 2023 | 28.65B | 28.87% |
| Dec 30, 2022 | 22.23B | 27.19% |
| Dec 31, 2021 | 17.48B | -5.05% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| FDC Limited | 62.32B |
| Gufic Biosciences | 30.71B |
| Hikal | 25.63B |
| Shukra Pharmaceuticals | 21.15B |
| Morepen Laboratories | 19.50B |
| Novartis India | 19.27B |
| Amrutanjan Health Care | 17.64B |
| Bliss GVS Pharma | 16.61B |